Ontology highlight
ABSTRACT:
SUBMITTER: Partridge AH
PROVIDER: S-EPMC6076042 | biostudies-other | 2014 Oct
REPOSITORIES: biostudies-other
Partridge Ann H AH Rumble R Bryan RB Carey Lisa A LA Come Steven E SE Davidson Nancy E NE Di Leo Angelo A Gralow Julie J Hortobagyi Gabriel N GN Moy Beverly B Yee Douglas D Brundage Shelley B SB Danso Michael A MA Wilcox Maggie M Smith Ian E IE
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20140902 29
<h4>Purpose</h4>To identify optimal chemo- and targeted therapy for women with human epidermal growth factor 2 (HER2)- negative (or unknown) advanced breast cancer.<h4>Methods</h4>A systematic review of randomized evidence (including systematic reviews and meta-analyses) from 1993 through to current was completed. Outcomes of interest included survival, progression-free survival, response, quality of life, and adverse effects. Guideline recommendations were evidence based and were agreed on by t ...[more]